Methyl Drostanolone 10mg
10 mg · 100 tablets · Oral anabolic research compound — Methyl Drostanolone 10 mg (Superdrol) is a powerful DHT-derived steroid known for rapid lean-mass and strength gains. With 3–5× testosterone’s receptor affinity and zero aromatisation, it’s ideal for hypertrophy studies—but requires caution due to high hepatotoxic risk and WADA S1 ban.
€ 44.00
Beschrijving
Methyl Drostanolone 10 mg
Brand: Magnus Pharmaceuticals
Content: 100 tablets | 10 mg per tablet
Price: €44
Manufactured in: Europe
🧪 Product Overview
Methyl Drostanolone 10 mg delivers the potent designer steroid known as Superdrol (methasterone), a 17-α-alkylated DHT-derived compound developed for strength and hypertrophy modeling in lab environments. With 3–5× the AR affinity of testosterone, it produces rapid muscle-mass and strength increases—balanced by a high risk of hepatotoxicity.
The compound’s ~8–10 h half-life and near-total oral bioavailability allow for precise oral-dosing studies. It remains banned under WADA S1, and detectable via long-term urinary markers.
✅ Key Research Highlights
-
Extreme anabolic drive: Demonstrates superior androgen-receptor binding vs. testosterone, supporting explosive hypertrophy research
-
Fast-response protocols: 4–6 week dosing yields significant body-mass and nitrogen-retention gains in resistance-trained subjects
-
Non-aromatising structure: Prevents estrogenic water gain and gynecomastia, useful in lean-mass studies
-
Oral bioavailability ~100%: Allows high-efficiency delivery without injection models
-
High detection sensitivity: Novel 17-epi metabolites enable LC-MS/MS detection >2 weeks post-dose
-
WADA status: Fully banned as an S1 anabolic agent—any exposure will yield a positive doping test
🔬 Suggested Laboratory Applications
-
Strength-gain and lean-hypertrophy modeling
-
Nitrogen retention and glycogen utilization studies
-
Hepatotoxicity mechanism mapping
-
Anti-doping detection validation
-
Androgen–receptor activation assays
📊 Technical Specifications
| Field | Data |
|---|---|
| Chemical Name | Methasterone (Methyldrostanolone) |
| Chemical Formula | C<sub>21</sub>H<sub>34</sub>O<sub>2</sub> |
| Synonyms | Superdrol; SDR; 2α,17α-dimethyl-5α-androstan-17β-ol-3-one |
| Molecular Weight | 318.5 g/mol |
| CAS Number | 3381-88-2 |
| Half-life (oral) | ≈ 8–10 h; peak concentration at 1–2 h |
| Documented Benefits | ↑ Lean muscle mass, ↑ strength, ↓ estrogenic water retention |
| Main Risks | Hepatotoxicity, jaundice, renal stress, lipid disruption, mood lability |
| Total Active Compound | 1,000 mg per carton (10 mg × 100 tablets) |
| Shelf-life | 36 months (manufacturer specification) |
| Detection Window | > 14 days via LC-MS/MS urinary metabolites |
⚙️ PubChem-Supported Research Insights
-
Provides aggressive lean-mass and strength gain in short-cycle models
-
Non-aromatising design limits estrogen-related side effects
-
Documented in multiple hepatotoxicity and dyslipidaemia case reports
-
Maintains high androgenic activity with no estrogen conversion
⚠️ Documented Research Side Effects
-
Cholestatic jaundice and hepatocellular stress after 2–7 weeks
-
Renal stress and hypertension reported in dose-escalation studies
-
HDL↓ / LDL↑ lipid shift, mood instability, and aggression risk
-
Virtually guaranteed anti-doping violation from metabolite trace detection
🧯 Handling & Compliance
For Research Use Only — Not for human or veterinary use
Store at ≤ 25°C in dry, light-protected conditions
Purchase confirms qualified researcher status
WADA-listed substance — doping test positive on any exposure
There are no reviews yet.
